SevenBridge Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.33M Buy
6,481
+364
+6% +$198K 0.52% 64
2025
Q4
$3.83M Buy
6,117
+83
+1% +$46.9K 0.62% 52
2025
Q3
$3.55M Buy
6,034
+1,079
+22% +$502K 0.58% 61
2025
Q2
$2.37M Buy
4,955
+1,371
+38% +$573K 0.42% 80
2025
Q1
$1.55M Buy
3,584
+1,674
+88% +$907K 0.31% 100
2024
Q4
$1.04M Buy
1,910
+959
+101% +$527K 0.2% 108
2024
Q3
$520K Buy
951
+152
+19% +$90K 0.1% 139
2024
Q2
$481K Buy
799
+349
+78% +$200K 0.11% 136
2024
Q1
$258K Buy
+450
New +$253K 0.06% 178
2018
Q4
Sell
-175
Closed -$43K 604
2018
Q3
$43K Buy
+175
New +$40.3K 0.02% 254

Other funds holding TMO

SevenBridge Financial Group's TMO Position: Q1 2026 in Review

SevenBridge Financial Group increased its Thermo Fisher Scientific (TMO) stake by 6% in Q1 2026, buying an estimated $198K and bringing the position to 6,481 shares worth $3.33M. The position accounts for 0.52% of the portfolio, ranked #64.

SevenBridge Financial Group first reported a position in TMO in Q3 2018 and has held it in 10 quarters since. The position peaked at $3.83M in Q4 2025. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • SevenBridge Financial Group held 6,481 shares of Thermo Fisher Scientific worth $3.33M as of Q1 2026.
  • SevenBridge Financial Group bought 364 Thermo Fisher Scientific shares in Q1 2026, an estimated $198K.
  • Thermo Fisher Scientific made up 0.52% of SevenBridge Financial Group's portfolio in Q1 2026, its #64 holding.
  • SevenBridge Financial Group first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 10 quarters since.
  • SevenBridge Financial Group's Thermo Fisher Scientific position peaked at $3.83M in Q4 2025.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on SevenBridge Financial Group's 13F filing for Q1 2026, filed 23 Apr 2026.